aid: cour-pharmaceuticals-development
name: Cour Pharmaceuticals Development
description: 'COUR Pharmaceuticals Development Co., Inc. (COUR Pharma) is a privately held,
  clinical-stage biotechnology company founded in 2012 and headquartered in the Chicago area
  (Northbrook/Skokie, Illinois), spun out of research at Northwestern University. COUR develops
  antigen-specific immune tolerance therapies built on its proprietary COUR Nanoparticle (CNP)
  platform: biodegradable polymer nanoparticles of roughly 500 nm carrying about 1% disease-specific
  antigen, which mimic apoptotic bodies so that antigen-presenting cells in the liver and spleen
  re-recognize the antigen as self, deleting pathogenic T cells and expanding regulatory T cells.
  Active clinical programs include CNP-103 for Type 1 Diabetes and CNP-106 for Myasthenia Gravis,
  with earlier work in Primary Biliary Cholangitis and Celiac Disease. COUR is a therapeutics
  developer, not a software or platform company: it publishes no developer program, no public API,
  and no machine-readable API contract of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/cour-pharmaceuticals-development/refs/heads/main/apis.yml
image: https://courpharma.com/wp-content/uploads/2025/06/Cour-OG.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-11'
modified: '2026-08-11'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Immunology
- Autoimmune Disease
- Clinical Trials
- Nanotechnology
- Drug Development
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cour-pharmaceuticals-development-domain-security.yml
- type: Website
  url: https://courpharma.com/
- type: About
  url: https://courpharma.com/about-us/
- type: Blog
  url: https://courpharma.com/news/
- type: BlogRSS
  url: https://courpharma.com/feed/
- type: Partners
  url: https://courpharma.com/partnerships/
- type: Careers
  url: https://courpharma.com/careers/
- type: PrivacyPolicy
  url: https://courpharma.com/privacy-policy/
- type: TermsOfService
  url: https://courpharma.com/terms-of-use/
- type: Accessibility
  url: https://courpharma.com/accessibility/
- type: SecondaryMarket
  url: https://forgeglobal.com/cour-pharmaceuticals-development_stock/
x-enrichment:
  date: '2026-08-11'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    COUR Pharma is a clinical-stage biotech developing CNP nanoparticle immune-tolerance
    therapies; its entire public site is a WordPress marketing/investor site with no developer
    section, api./developer./docs.courpharma.com do not resolve in DNS, and every contract and
    /.well-known/ probe returned the site's HTML 404 — the only machine-readable endpoint on the
    host is stock WordPress /wp-json/ CMS plumbing (Elementor, Astra, Forminator), not a product API.
  evidence:
  - url: https://courpharma.com/openapi.json
    status: 404
  - url: https://courpharma.com/.well-known/agent-card.json
    status: 404
  - url: https://courpharma.com/.well-known/security.txt
    status: 404
  - url: https://courpharma.com/llms.txt
    status: 404
  - url: https://courpharma.com/graphql
    status: 404
  - url: https://api.courpharma.com/
    status: 0
  checked: '2026-08-11'